Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 22, 2021
Sygnature Discovery has begun expanding into new laboratories at Bruntwood SciTech’s Alderley Park.
read more
Monday, February 22, 2021
Intravacc announced its new modern pilot production plant will soon be operational.
read more
Monday, February 22, 2021
Wavelength Pharmaceuticals announced the acquisition of a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
read more
Monday, February 22, 2021
Catalent recently signed a multi-year commercial supply agreement with Aurinia for LUPKYNIS, a drug to treat adult patients with lupus nephritis.
read more
Monday, February 22, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Monday, February 22, 2021
Eli Lilly and Rigel announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552.
read more
Wednesday, February 24, 2021
Eurofins Scientific has announced the acquisition of Beacon Discovery, a drug discovery and CRO focused on GPCR research.
read more
Wednesday, February 24, 2021
MaxiVAX and Minaris Regenerative Medicine GmbH have entered into a manufacturing agreement for MVX-ONCO-2.
read more
Wednesday, February 24, 2021
Vaccinex announced Surface Oncology will be exercising its option to license the anti-CCR8 antibody discovered via Vaccinex’s ActivMAb antibody discovery and novel viral display platform.
read more
Wednesday, February 24, 2021
AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.
read more
Wednesday, February 24, 2021
GT Biopharma has signed an expanded GMP manufacturing agreement with Cytovance Biologics for the manufacture of all TriKEs™.
read more
Wednesday, February 24, 2021
Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies.
read more
Thursday, February 25, 2021
ERS Genomics has announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Thursday, February 25, 2021
Amyris announced promising preliminary data in a pre-clinical study of its RNA COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
read more
Thursday, February 25, 2021
Notal Vision announced the company will provide AsclepiX Therapeutics with Home OCT monitoring services through its Notal Vision Diagnostic Clinic to support AsclepiX’s AXT107 phase 1 clinical trial program.
read more